However, little is known about the utility of selected circulating blood inflammatory mediators such as cytokines, including HCs and chemokines, and acute-phase protein—CRP—as well as various MMPs and TIMPs in patients with CRC. The gene discussed is CRP; the disease is colorectal carcinoma.